Company intelligence / Profile preview

Ultimate Keen

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Ultimate Keen appears to be a legal entity used as an investment or holding vehicle rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly indexed sources tie the name to Companies House records in the UK and to SEC-related ownership disclosures as a reporting owner in biotech companies including Aduro Biotech and Chinook Therapeutics. However, there is no evidence from the available sources that Ultimate Keen itself develops therapeutics, diagnostics, or healthcare products. Based on the available information, it should not be classified as a biotech or healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on Ultimate Keen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultimate Keen.

Explore the full profile